Blood cancers, Polycythaemia
Results
Phase 1/2
This trial looked at a drug called givinostat to treat a blood disorder called polycythaemia vera.
Polycythaemia vera is a . This means a condition in which the produces too many blood cells. In polycythaemia, this is too many .
This trial was open for people to join between 2014 and 2017. The team published the results in 2020 and 2021.
Recruitment start: 11 April 2014
Recruitment end: 30 June 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Mary McMullin
Italfarmaco
Last reviewed: 07 Feb 2023
CRUK internal database number: 12163
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
